Search Results
201 items found for "chronic kidney disease"
- Therapeutic validation of an orphan G protein‐coupled receptor
as sensory perception, reproduction, development, growth, metabolism, and are also linked to major diseases , such as neuroinflammatory, metabolic and autoimmune diseases. GPR84 has been additionally proposed to be a potential biomarker in different inflammatory diseases ( GPR84 is a promising target to exploit and the investment in better tools to study its function in both disease
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
The sheer complexity of the cell and the astonishing diversity of diseases are just two reasons why researchers typically require years to uncover the mechanisms of disease before they can even dare to contemplate
- The development of modulators for lysophosphatidic acid receptors: A comprehensive review
signaling pathway has captured an increasing amount of attention because of its involvement in various diseases , such as idiopathic pulmonary fibrosis, cancers, cardiovascular diseases and neuropathic pain, making development targeting LPA receptors to modulate LPA signaling and their therapeutic potential in various diseases
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
This high-resolution mapping can confirm the protein’s role in disease pathology and highlight allosteric Resistance A significant challenge in drug development, particularly in the treatment of infectious diseases The choice of model systems, such as yeast, bacteria, or mammalian cells, can heavily influence the method's systems, including multicellular organisms and human cells, to better mimic physiological conditions and disease
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease The prevalence of non-alcoholic fatty liver disease (NAFLD) is globally increasing. Gaining control over disease-related events in non-alcoholic steatohepatitis (NASH), an advanced form
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
Repurposing Vaptans "Men with advanced prostate cancer are treated by androgen deprivation therapy but the disease cancer patient sample data revealed that coexpression of AVPR1A and AVPR2 is highly correlated with disease
- 📰 GPCR Weekly News, April 22 to 28, 2024
tyrosine kinase IGF1R and its associated GPCRs are co-regulated by the noncoding RNA NEAT1 in Alzheimer's disease characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer's disease assays Generation of a deep mouse brain spectral library for transmembrane proteome profiling in mental disease
- RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα
August 2022 "Aims: The pathophysiological mechanism(s) underlying non-alcoholic fatty liver disease (
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
receptor (GPCR) GPR35 is involved in oncogenic signaling, bacterial infections, and inflammatory bowel disease transducer interactions and allow for mechanism-based therapies against, for example, inflammatory bowel disease
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
therapeutic strategies aimed at targeting specific phosphorylation events to modulate G protein signaling in disease our understanding of cellular signaling dynamics and open new avenues for therapeutic intervention in diseases
- Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR
GPCRs, including β2AR, play key roles in various conditions, such as asthma, cardiovascular diseases, These insights have the potential to advance the treatment of various diseases involving GPCR signalling
- Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for ...
UdM”), to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) in a metabolic disease
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
D2LR, D3R, and D4R, vasopressin V1AR, and serotonin 5-HT1AR are noted in various neurodegenerative diseases antagonism, kurarinone might be a potential compound that can alleviate clinical symptoms of Parkinson's disease
- Platelets in the NETworks interweaving inflammation and thrombosis
NETs were also detected in thrombotic lesions in several disease backgrounds, pointing towards a role between platelets and NETs and the potential of this alliance to influence the course of inflammatory diseases
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
for their work on GPCR gene variants and human genetic disease Ilana Kotliar , Thomas Sakmar , et al. Intelligence Reviews, GPCRs, and more G protein-coupled receptor (GPCR) gene variants and human genetic disease
- Function and structure of bradykinin receptor 2 for drug discovery
regulation of B2R, which shed light on structure-based drug design for the treatment of B2R-related diseases
- Diversification of PAR signaling through receptor crosstalk
novel mechanism providing diversity to receptor function and play important roles in physiology and disease
- AELIS PHARMA launches their IPO for €25 million
fundraising gives us the means to achieve our ambitions: to become a leading player in the field of brain diseases
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
for developing therapeutic agents that target specific receptor dimer states to modulate signaling in diseases Perreault, M.L., et al., Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease
- Structural view of G protein-coupled receptor signaling in the retinal rod outer segment
advanced our understanding of rod outer segment (ROS) morphology and the pathological basis of retinal diseases
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
Promising preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases
- 📰 GPCR Weekly News - January 2 to 8, 2023
Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological Diseases Manager Director of Molecular Pharmacology, Discovery Biology Staff Scientist/Senior Staff Scientist, Disease
- Developing the Cannabinoid Receptor 2 (CB2) pharmacopeia: past, present, and future
Promising preclinical data support the applicability of CB2 activation in autoimmune and inflammatory diseases
- Posttranslational modifications in GPCR internalization
significance in GPCR internalization dynamics, internalization routes, postinternalization fates, and related diseases
- 📰 GPCR Weekly News, March 4 to 10, 2024
modulator VU0486846 reduces neurogliosis in female Alzheimer's mice The association of GNB5 with Alzheimer disease of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models of Alzheimer's disease
- Chemerin Forms: Their Generation and Activity
The levels of chemerin in circulation are correlated with certain disease conditions, such as patients
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases